Skip to main content

Strategies to manage antifungal drug resistance.

Publication ,  Journal Article
Tseng, H-K; Perfect, JR
Published in: Expert Opin Pharmacother
February 2011

INTRODUCTION: Invasive fungal infections continue to cause significant morbidity and mortality in immunocompromised hosts. From more than half a million deaths from cryptococcosis in sub-Saharan Africa to an unchanging death rate from invasive candidiasis, despite three antifungal classes of drugs, insights into better strategies to reduce therapeutic failures or resistance are needed. AREAS COVERED: This review examines the issues around antifungal drug resistance from both a basic description of the failures and how they are detected to the variety of issues that need to be addressed to help prevent failures for successful management. The reader will gain an understanding of the clinical complexities in this patient population for management of invasive fungal infections. Throughout the review, principles of management are given along with some specific clinical examples to illustrate the issues and frame the knowledge base. From this discussion it is hoped that the clinician can use the insights provided to manage individual patients and find links to the evidence-based material that support its conclusions. Also, this review specifically identifies the limitations of present management and directs clinicians to gather additional information and provide even better treatment strategies. EXPERT OPINION: Invasive fungal infections are life-threatening complications of serious underlying diseases. Their management can be complicated by both direct and clinical drug resistance and by understanding these possibilities and correcting them; most patients can be successfully managed with present antifungal drugs if the underlying diseases can be controlled.

Duke Scholars

Published In

Expert Opin Pharmacother

DOI

EISSN

1744-7666

Publication Date

February 2011

Volume

12

Issue

2

Start / End Page

241 / 256

Location

England

Related Subject Headings

  • Pharmacology & Pharmacy
  • Mycoses
  • Humans
  • Fungi
  • Drug Resistance, Fungal
  • Antifungal Agents
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tseng, H.-K., & Perfect, J. R. (2011). Strategies to manage antifungal drug resistance. Expert Opin Pharmacother, 12(2), 241–256. https://doi.org/10.1517/14656566.2010.517195
Tseng, Hsiang-Kuang, and John R. Perfect. “Strategies to manage antifungal drug resistance.Expert Opin Pharmacother 12, no. 2 (February 2011): 241–56. https://doi.org/10.1517/14656566.2010.517195.
Tseng H-K, Perfect JR. Strategies to manage antifungal drug resistance. Expert Opin Pharmacother. 2011 Feb;12(2):241–56.
Tseng, Hsiang-Kuang, and John R. Perfect. “Strategies to manage antifungal drug resistance.Expert Opin Pharmacother, vol. 12, no. 2, Feb. 2011, pp. 241–56. Pubmed, doi:10.1517/14656566.2010.517195.
Tseng H-K, Perfect JR. Strategies to manage antifungal drug resistance. Expert Opin Pharmacother. 2011 Feb;12(2):241–256.

Published In

Expert Opin Pharmacother

DOI

EISSN

1744-7666

Publication Date

February 2011

Volume

12

Issue

2

Start / End Page

241 / 256

Location

England

Related Subject Headings

  • Pharmacology & Pharmacy
  • Mycoses
  • Humans
  • Fungi
  • Drug Resistance, Fungal
  • Antifungal Agents
  • 3214 Pharmacology and pharmaceutical sciences
  • 1115 Pharmacology and Pharmaceutical Sciences